ADVFN US – Market Content Editor

Lexeo Therapeutics Inc (NASDAQ:LXEO) saw its stock rise 2.3% after the U.S. Food and Drug Administration granted breakthrough therapy designation to its gene therapy candidate for Friedreich ataxia, LX2006. This designation was awarded based on interim clinical results that demonstrated significant improvements in cardiac biomarkers and functional outcomes. LX2006 was also chosen for the FDA’s…

Shares of ParaZero Technologies Ltd. (NASDAQ:PRZO) rose 7% after the company showcased its DefendAir Personal Net Gun System in a successful live field demonstration that captured the attention of Israeli defense authorities. The event, held in Kfar Saba, Israel, featured real-time interception exercises where the DefendAir system neutralized every drone threat presented—including passive drones that…

Shares of POET Technologies Inc. (NASDAQ:POET) slid 9.2% on Monday following news of a $25 million public offering priced well below the company’s previous closing value. The Toronto-based photonics firm announced plans to issue 5 million units at a price of $5.00 each, representing a 12% discount to Friday’s closing price on the TSX Venture…

Webull Corporation (NASDAQ:BULL) shares dropped 9% after the trading platform revealed a major financing deal that could result in significant share dilution over time. The company announced it has entered into a standby equity purchase agreement with Yorkville Advisors, giving Webull the option to issue up to $1 billion worth of Class A ordinary shares…

Jasper Therapeutics (NASDAQ:JSPR) saw its shares plummet over 43% in premarket trading on Monday after the biotech firm disclosed manufacturing problems linked to one of its drug product lots, casting uncertainty over key clinical programs. The company revealed that certain dosing groups in its ongoing chronic spontaneous urticaria trial involving the investigational antibody briquilimab may…

IREN Limited (NASDAQ:IREN) shares climbed 5% on Monday after the tech-driven infrastructure firm announced it had reached its 50 exahash per second (EH/s) Bitcoin mining goal ahead of schedule and made significant strides in expanding its AI cloud fleet. The company reported a record month for mining revenue in June, generating $65.5 million, a slight…

KalVista Pharmaceuticals, Inc. (NASDAQ:KALV) saw its stock soar by 19% after receiving FDA approval for EKTERLY (sebetralstat)—the first oral, on-demand treatment for hereditary angioedema (HAE), a rare and potentially life-threatening genetic condition. The green light from regulators represents a major breakthrough for HAE patients, who until now had no alternative to injectable therapies for managing…

Rocket Lab USA Inc. (NASDAQ:RKLB) saw its stock climb 3% in Monday’s pre-market session, as investors showed renewed interest in SpaceX rivals amid a deepening public feud between Elon Musk and President Donald Trump. The boost in Rocket Lab shares comes as Tesla Inc. (NASDAQ:TSLA) dropped nearly 7% after Musk revealed plans over the weekend…

Sandstorm Gold Ltd. (NYSE:SAND) saw its stock rise by 7% on Monday following news that Royal Gold Inc. (NASDAQ:RGLD) will acquire both Sandstorm and Horizon Copper, in a major consolidation move aimed at expanding Royal Gold’s footprint in the North American gold streaming and royalty sector. In the announced all-stock deal, Royal Gold will acquire…

Shares of Cogent Biosciences Inc. (NASDAQ:COGT) climbed 10% on Monday following the release of highly promising top-line data from its SUMMIT trial, evaluating bezuclastinib in patients with non-advanced systemic mastocytosis (NonAdvSM). According to the company, the experimental therapy achieved statistically significant results across all primary and key secondary endpoints. At week 24, patients receiving bezuclastinib…